New Jersey 2022-2023 Regular Session

New Jersey Senate Bill SJR31

Introduced
1/18/22  

Caption

Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.

Impact

The establishment of the commission is expected to lead to uniform standards for opioid antidote administration aftercare, which may influence how hospitals develop protocols and procedures for treating patients who have experienced opioid overdoses. This can potentially lead to more comprehensive care and better recovery outcomes for individuals struggling with substance use disorders. By creating a structured set of recommendations, SJR31 aims to ensure that hospitals are prepared to provide adequate support during a vulnerable stage in these patients' lives.

Summary

SJR31, introduced in the New Jersey Legislature, aims to establish a temporary Commission on Opioid Antidote Administration and Aftercare. The resolution is motivated by the need to improve how hospitals handle the release of patients who have received opioid antidotes, like naloxone. The commission is tasked with studying current procedures across hospitals in New Jersey and other states to evaluate their effectiveness and determine best practices for providing aftercare to these patients, thereby promoting their health and recovery upon discharge from hospital care.

Contention

While the bill emphasizes improving patient outcomes, it may generate discussion concerning the implications of increased oversight and standardization on healthcare provider autonomy. Some may argue that tailored, local responses are crucial for effectively addressing individual patient needs, particularly in a field as complex as addiction treatment. The temporary nature of the commission means its findings could influence future legislation and practices, but there remain concerns about how standardized protocols may be adapted to fit the diverse circumstances of different hospitals and communities.

Companion Bills

No companion bills found.

Previously Filed As

NJ SJR25

Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.

NJ A277

Authorizes public libraries to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by librarian or other trained library employee.

NJ A1170

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ S3678

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ A5580

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ S186

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ A3749

Establishes position of Statewide Opioid Antidote Coordinator.

NJ S2301

Establishes position of Statewide Opioid Antidote Coordinator.

NJ A284

Establishes position of Statewide Opioid Antidote Coordinator.

NJ S2808

Establishes Statewide Opioid Antidote Coordinator position; appropriates funds.

Similar Bills

CA AB870

Prisoners: mental health treatment.

NJ SJR25

Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.

CA AB1058

Medi-Cal: specialty mental health services and substance use disorder treatment.

CA SB46

Controlled substances: treatment.

CA AB1750

Controlled substances: treatment.

CA SB889

California Department of Tax and Fee Administration: earnings withholding orders: settlement agreements: excise taxes.

CA SB904

Controlled substances: treatment.

CA AB1998

Opioids: safe prescribing policy.